geraniol has been researched along with Degenerative Diseases, Central Nervous System in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Huang, X; Liu, Y; Rehman, HM; Zhou, S | 1 |
| Beggiato, S; Botti, G; Dalpiaz, A; de Oliveira Junior, ER; Ferraro, L; Graziani, D; Iannuccelli, V; Leo, E; Lima, EM; Maretti, E; Rustichelli, C; Truzzi, E | 1 |
2 other study(ies) available for geraniol and Degenerative Diseases, Central Nervous System
| Article | Year |
|---|---|
Mechanistic insight of the potential of geraniol against Alzheimer's disease.
Topics: Acyclic Monoterpenes; Alzheimer Disease; Cholinergic Agents; Drugs, Chinese Herbal; Humans; Ligands; Molecular Docking Simulation; Neurodegenerative Diseases; Receptor, Muscarinic M3 | 2022 |
Nasal biocompatible powder of Geraniol oil complexed with cyclodextrins for neurodegenerative diseases: physicochemical characterization and in vivo evidences of nose to brain delivery.
Topics: 2-Hydroxypropyl-beta-cyclodextrin; Acyclic Monoterpenes; Animals; Brain; Cyclodextrins; Neurodegenerative Diseases; Powders; Rats; Solubility; Spectroscopy, Fourier Transform Infrared | 2021 |